Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
LEF1 | hg19_v2_chr4_-_109087906_109087953 | -0.46 | 7.8e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_124553437 Show fit | 7.25 |
ENST00000517956.1
ENST00000443022.2 |
F-box protein 32 |
|
chr5_+_140480083 Show fit | 7.06 |
ENST00000231130.2
|
protocadherin beta 3 |
|
chr10_+_123970670 Show fit | 6.63 |
ENST00000496913.2
|
transforming, acidic coiled-coil containing protein 2 |
|
chr11_-_111794446 Show fit | 6.09 |
ENST00000527950.1
|
crystallin, alpha B |
|
chr7_-_27219849 Show fit | 5.96 |
ENST00000396344.4
|
homeobox A10 |
|
chr1_+_78383813 Show fit | 5.56 |
ENST00000342754.5
|
nexilin (F actin binding protein) |
|
chr3_+_173302222 Show fit | 5.04 |
ENST00000361589.4
|
neuroligin 1 |
|
chr10_+_54074033 Show fit | 4.92 |
ENST00000373970.3
|
dickkopf WNT signaling pathway inhibitor 1 |
|
chr3_-_149375783 Show fit | 4.68 |
ENST00000467467.1
ENST00000460517.1 ENST00000360632.3 |
WW domain containing transcription regulator 1 |
|
chr21_+_40823753 Show fit | 4.67 |
ENST00000333634.4
|
SH3 domain binding glutamic acid-rich protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 21.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.5 | 20.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 15.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 12.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 11.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.6 | 11.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 8.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.4 | 8.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 8.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 8.2 | GO:0045727 | positive regulation of translation(GO:0045727) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 39.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 28.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 17.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 11.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 10.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 9.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 9.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 9.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 9.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 8.6 | GO:0031045 | dense core granule(GO:0031045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 25.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 12.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 11.4 | GO:0001618 | virus receptor activity(GO:0001618) |
1.6 | 11.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 10.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 7.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 7.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 7.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 7.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.7 | 7.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 20.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 9.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 8.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 8.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 7.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 6.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 6.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 6.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 6.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 18.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 15.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 12.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 11.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 11.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 8.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 8.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 7.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 6.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 5.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |